01 Mar Cardio Diagnostics Press Release Jan 28
Cardio Diagnostics’ Epi+Gen CHD at-home sampling kit: Potential patients fill out a screening questionnaire that is reviewed by a board-certified clinician. If eligible for the test, a sampling kit is sent to their home. After the sample is collected, it is shipped using the enclosed prepaid mailer to our partner CLIA-certified lab for processing using our patent-pending, artificial intelligence guided procedures. After approval by a board-certified pathologist, the results are released to the ordering clinician for review and discussion with the patient.
Read the full news here.